Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on May 29, 2014 2:59pm
255 Views
Post# 22611653

Maybe our Pierre's cousin?

Maybe our Pierre's cousin?

Mulroney to Be Named Chairman in Quebecor Overhaul

May 29, 2014

Quebecor Inc. (QBR/B), the owner of Quebec’s largest circulation newspaper, plans to name former Canadian prime minister Brian Mulroney as chairman of its board following the annual shareholders’ meeting next month.

Mulroney, currently vice chairman, will replace Francoise Bertrand, who decided not to seek re-election, Montreal-based Quebecor said in a filing yesterday. Pierre Laurin will be named vice chairman and lead director.

The moves follow a string of leadership changes at the company, after vice chairman and controlling shareholder Pierre-Karl Peladeau, who spent 14 years as CEO before giving up the post last year, resigned in March to run as a candidate in the Quebec provincial elections. Robert Depatie, who became CEO in May 2013, also announced his resignation last month, citing health reasons.

Mulroney, 75, has been a director of Quebecor since 1999, according to the filing. He’s also a senior partner at Norton Rose Fulbright LLP and a director at Blackstone Group LP and Wyndham Worldwide Corp.

Quebecor will hold its annual meeting in Montreal on June 19.

To contact the reporter on this story: Liezel Hill in Toronto at lhill30@bloomberg.net

Bullboard Posts